IRLAB Therapeutics
IRLAB to present at Life Science-dagen in Gothenburg and have a fireside chat with ABG
Gothenburg, Sweden, February 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the event Life Science-dagen in Gothenburg on March 6. The company will also participate in a fireside chat with ABG, to be published on March 6.
At Life Science-dagen, the company will be presented by Viktor Siewertz, CFO at IRLAB, who will give a 20-minute presentation of the company followed by a 10-minute Q&A at 09:15–09:45. The event is held at Wallenberg Conference Centre, Medicinaregatan 20, Gothenburg. The event is live streamed and can be viewed afterwards on the event website.
More information can be found on www.lifesciencedagen.se
The fireside chat hosted by ABG will be a conversation between Viktor Siewertz, CFO at IRLAB and ABG’s analyst. The conversation will be recorded and published on ABG’s website for commissioned research during March 6, 2024.
For the fireside chat and more IRLAB related content, please visit https://cr.abgsc.com/foretag/irlab-therapeutics/Media/
Datum | 2024-02-29, kl 07:00 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)